"Topical Solasodine Rhamnosyl Glycosides Derived From the Eggplant Treats Large Skin Cancers: Two Case Reports"
written by Bill E. Cham,
published by International Journal of Clinical Medicine, Vol.2 No.4, 2011
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] Skin cancer and role of herbal medicines
2018
[2] Follow Blog via Email
2018
[3] Solasodine, Solamargine and Mixtures of Solasodine Rhamnosides: Pathway to Expansive Clinical Anticancer Therapies
2017
[4] Aglycone solanidine and solasodine derivatives: A natural approach towards cancer
Biomedicine & Pharmacotherapy, 2017
[5] Опыт применения препарата Курадерм в лечении базально-клеточного рака кожи головы и шеи
2016
[6] The Steroidal Glycoalkaloids from Solanaceae: Toxic Effect, Antitumour Activity and Mechanism of Action
Planta medica, 2016
[7] Synthesis of the tetrasaccharide glycoside moiety of Solaradixine and rapid NMR-based structure verification using the program CASPER
Tetrahedron, 2016
[8] Treatment of Skin Cancer with a Selective Apoptotic-Inducing CuradermBEC5 Topical Cream Containing Solasodine Rhamnosides
International Journal of Clinical Medicine, 2015
[9] Treatment of Non Melanoma Skin Cancers: An Intra-Comparison Study of CuradermBEC5 and Various Established Modalities
Journal of Cancer Therapy, 2015
[10] Treatment of Skin Cancer with a Selective Apoptotic-Inducing Curaderm^ sup BEC5^ Topical Cream Containing Solasodine Rhamnosides
International Journal of Clinical Medicine, 2015
[11] A Standardized Plant Extract Containing a Target Compound Is Acceptable as a Potent Therapeutic Entity. Relevance to BEC and Solamargine, Example of a …
2015
[12] A Standardized Plant Extract Containing a Target Compound is Acceptable as a Potent Therapeutic Entity: Relevance to BEC and Solamargine, a Topical Clinical Formulation Curaderm BEC5
Journal of Cancer Treatment and Research, 2015
[13] A Standardized Plant Extract Containing a Target Compound Is Acceptable as a Potent Therapeutic Entity: Relevance to BEC and Solamargine, a Topical …
2015
[14] Some Indian vegetables used as anticancer agent
SCIENCES, 2014
[15] A review of solasodine rhamnosides therapy for in-situ squamous cell carcinoma on the penis.
British Journal of Medicine and Medical Research, 2014
[16] A review of solasodine rhamnosides therapy for in-situ squamous cell carcinoma on the penis
British Journal of Medicine and Medical Research, 2014
[17] Solasodine Glycosides: A Topical Therapy for Actinic Keratosis. A Single-Blind, Randomized, Placebo-Controlled, Parallel Group Study with Curaderm BEC5
2013
[18] Topical Curaderm BEC5 Therapy for Periocular Nonmela-noma Skin Cancers: A Review of Clinical Outcomes
2013
[19] Search Types
Journal of Drugs in Dermatology, 2013
[20] Drug therapy: Solamargine and other solasodine rhamnosyl glycosides as anticancer agents
2013
[21] Topical CuradermBEC5 Therapy for Periocular Nonmela-noma Skin Cancers: A Review of Clinical Outcomes
International Journal of Clinical Medicine, 2013
[22] Solasodine Glycosides: A Topical Therapy for Actinic Keratosis. A Single-Blind, Randomized, Placebo-Controlled, Parallel Group Study with CuradermBEC5
Journal of Cancer Therapy, 2013
[23] Intralesion and CuradermBEC5 Topical Combination Therapies of Solasodine Rhamnosyl Glycosides Derived from the Eggplant or Devil’s Apple Result in Rapid Removal of Large Skin Cancers. Methods of Treatment Compared
International Journal of Clinical Medicine, 2012
[24] Solasodine rhamnosyl glycosides cause apoptosis in cancer cells. Do they also prime the immune system resulting in long-term protection against cancer?
Planta medica, 2012
[25] Intralesion and curaderm BEC5 topical combination therapies of solasodine rhamnosyl glycosides derived from the eggplant or devil's apple result in rapid …
2012
[26] Intralesion and curadermBEC5 topical combination therapies of solasodine rhamnosyl glycosides derived from the eggplant or devil's apple result in rapid …
2012
[27] CuradermBEC5 for Skin Cancers, Is It? An Overview
2011
[28] Curaderm BEC5 for skin cancers, is it? An overview
Journal of Cancer Therapy, 2011